nicotine has been researched along with Schizophrenia in 237 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.69) | 18.7374 |
| 1990's | 34 (14.35) | 18.2507 |
| 2000's | 89 (37.55) | 29.6817 |
| 2010's | 89 (37.55) | 24.3611 |
| 2020's | 21 (8.86) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu-Villaça, Y; Couto, LA; Dutra-Tavares, AC; Filgueiras, CC; Maia, JG; Manhães, AC; Ribeiro-Carvalho, A; Semeão, KA | 1 |
| Grace, AA; Sved, AF; Weeks, JJ | 1 |
| George, TP; Johnstone, S; Rabin, RA; Sorkhou, M | 1 |
| Chen, D; Dai, Q; Tian, Y; Wang, D; Wang, L; Wang, W; Wei, S; Xia, L; Xiu, M; Zhang, X; Zhou, H; Zhu, R | 1 |
| Amini-Sardouei, S; Ezzatabadipour, M; Khaksari, M; Nozari, M; Parvan, M; Salmani, N; Shabani, M | 1 |
| Humair, JP; Papachristou, C | 1 |
| Albert, KM; Armstrong, K; Conley, AC; Johnson, JV; Kem, WR; Lewis, AS; Newhouse, PA | 1 |
| Bahji, A; Bousman, CA; Danilewitz, M; Honer, WG; Mathew, N; Rafizadeh, R; Schütz, CG; White, RF | 1 |
| Dondé, C; Polosan, M; Pouchon, A | 1 |
| Falkai, P; Hasan, A; Muenz, S; Nitsche, MA; Padberg, F; Papazova, I; Pross, B; Strube, W | 1 |
| Goodwin, C; Murphy, CM; Onu, MC; Tidey, JW; Williams, DM | 1 |
| Abreu-Villaça, Y; Dutra-Tavares, AC; Filgueiras, CC; Manhães, AC; Ribeiro-Carvalho, A; Rodríguez-Vega, A; Semeão, KA; Souza, TP | 1 |
| Buchanan, RW; Hahn, B; Shrieves, ME; Wells, AK; Yuille, MB | 1 |
| Kaiser, S; Sabe, M; Zhao, N | 1 |
| Brunelin, J; Cellard, C; Dondé, C; Haesebaert, F; Mondino, M; Rolland, B | 1 |
| Firth, J; Kisely, S; Siskind, DJ; Wong, TT; Wu, BT | 1 |
| Arioka, Y; Goto, S; Kitagaki, S; Kushima, I; Mamiya, T; Mouri, A; Noda, Y; Ozaki, N; Uchida, M; Yamada, S; Yoshimi, A | 1 |
| Barnes, SA; Bobba, V; Carroll, C; Grottick, AJ; MacQueen, DL; Sanabria, EK; Young, JW | 1 |
| Caponnetto, P; DiPiazza, J; Kim, J; Maglia, M; Polosa, R | 1 |
| Arranz, B; Arrojo, M; Becoña, E; Bernardo, M; Castells, X; Cunill, R; Flórez, G; Fonseca, F; Garriga, M; Goikolea, JM; González-Pinto, A; López, A; Sáiz, PA; San, L; Tirado-Muñoz, J; Torrens, M; Zorrilla, I | 1 |
| Coen, KM; Fletcher, PJ; Lê, AD; Li, Z | 1 |
| Feng, M; Li, M; Sparkman, NL; Sui, N | 1 |
| Boggs, DL; Cosgrove, K; D'Souza, DC; Esterlis, I; Pittman, B; Ranganathan, M; Sewell, RA; Surti, TS | 1 |
| Brennan, KA; Ellenbroek, BA; Waterhouse, U | 1 |
| Cannon, TD; Gupta, R; He, L; Hiekkalinna, TS; Kaprio, J; Korhonen, T; Loukola, A; Madden, PAF; Milani, L; Ollikainen, M; Perola, M; Qaiser, B; Ripatti, S; Salomaa, V; Therman, S; Zheutlin, AB | 1 |
| Baker, JT; Caine, CE; Calderon, V; Evins, AE; Janes, AC; Moran, LV; Ongur, D; Pizzagalli, DA; Stoeckel, LE; Villafuerte, R; Wang, K | 1 |
| Brown, RW; Burgess, KC; Cummins, ED; DePreter, CC; Gill, WD; Kirby, SL; Owens, AS; Schlitt, MA | 1 |
| Avvisati, L; Buonaguro, EF; de Bartolomeis, A; Iasevoli, F; Latte, G; Marmo, F; Tomasetti, C | 1 |
| Jakšić, N; Mihaljević-Peleš, A; Pivac, N; Rojnić Kuzman, M; Šagud, M; Vuksan-Ćusa, B | 1 |
| Bailey, A; Georgiou, P; Hambsch, B; Keyworth, H; Kitchen, I; Otte, DM; Zanos, P; Zimmer, A | 1 |
| Davis, DR; Denlinger-Apte, RL; Gaalema, DE; Miller, ME; Pericot-Valverde, I; Tidey, JW | 1 |
| Chen, H; Cui, Q; Duan, X; Fan, YS; Li, J; Liao, W; Yang, S | 1 |
| Bell, RL; Chambers, RA; Engleman, EA; Sentir, AM | 1 |
| Inami, R; Kirino, E | 1 |
| Brunette, MF; Green, AI; Pizzagalli, DA; Roth, RM; Whitton, AE; Williams, JM | 1 |
| Donny, EC; Grace, AA; Rupprecht, LE; Sved, AF; Weeks, JJ | 1 |
| Mihaljevic Peles, A; Pivac, N; Sagud, M | 1 |
| Brousse, G; de Chazeron, I; Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Schmitt, A; Underner, M | 1 |
| Chen, H; Du, L; Fan, YS; Li, J; Liao, W; Meng, Y; Yang, S | 1 |
| Porwal, M; Tsoi, DT; Webster, AC | 2 |
| Chen, HK; Lee, SM; Wu, BJ | 1 |
| Ahmed, T; Allan, J; Gordon, R; Ragg, M | 1 |
| Concheiro-Guisan, M; Gold, JM; Hahn, B; Harvey, AN; Holcomb, HH; Huestis, MA | 1 |
| Choueiry, J; de la Salle, S; Dort, H; Impey, D; Knott, V; Phillipe, T; Smith, D | 1 |
| Morrens, M; Quisenaerts, C; Sabbe, B | 1 |
| Barr, MS; George, TP; Mackowick, KM; Ouellet-Plamondon, C; Rabin, RA; Wing, VC | 1 |
| Daum, I; Thoma, P | 1 |
| Boggs, DL; D'Souza, DC; Madonick, S; Ranganathan, M; Sewell, RA | 1 |
| de Bruijn, E; De la Asuncion, J; Dumont, G; Hulstijn, W; Morrens, M; Quisenaerts, C; Sabbe, B; Streffer, J; Timmers, M | 1 |
| Freedman, R | 2 |
| Dawson, GR; Dourish, CT | 1 |
| Boggs, DL; Carlson, J; Cortes-Briones, J; D'Souza, DC; Krystal, JH | 1 |
| Bailey, A; Hambsch, B; Keyworth, H; Kitchen, I; Lind, J; Otte, DM; Racz, I; Zimmer, A | 1 |
| Aguglia, E; Alamo, A; Auditore, R; Caponnetto, P; Maglia, M; Minutolo, G; Palermo, F; Polosa, R; Signorelli, M | 1 |
| AhnAllen, CG; Bidwell, LC; Tidey, JW | 1 |
| Gupta, T; Mittal, VA | 1 |
| Fehsel, K; Henning, U; Korth, C; Luckhaus, C; Schäble, S; Silva, MA; Trossbach, SV; Winterer, G | 1 |
| Bell, RL; Berg, SA; Chambers, RA; Engleman, EA; Sentir, AM | 1 |
| Blier, P; Fisher, D; Illivitsky, V; Knott, V; Smith, DM | 1 |
| Herzog, MH; Kunchulia, M; Pilz, KS | 1 |
| Henderson, Z; Lu, C; Song, J; Wang, J; Wang, X; Wang, Y; Wang, Z; Zhang, X | 1 |
| Kohlhaas, KL; Robb, HM; Roderwald, VA; Rueter, LE | 1 |
| Featherstone, RE; Siegel, SJ | 1 |
| Li, M; Mulholland, MM; Schulz, TD; Swalve, N | 1 |
| Olincy, A; Rojas, DC; Smucny, J; Tregellas, JR | 1 |
| Cassidy, RN; Miller, ME; Tidey, JW | 1 |
| Olincy, A; Smucny, J; Tregellas, JR | 1 |
| Brown, AS; Cheslack-Postava, K; Hinkka-Yli-Salomäki, S; McKeague, IW; Niemelä, S; Sourander, A; Surcel, HM | 1 |
| Brennan, KA; Ellenbroek, BA; Roper, VE; Waterhouse, U | 1 |
| Sumikawa, K; Yamazaki, Y | 1 |
| Changeux, JP; DiGregorio, DA; Gutkin, BS; Hoeffer, CA; Koukouli, F; Levenga, J; Maskos, U; Nilges, M; O'Neill, HC; Rooy, M; Sailor, KA; Stitzel, JA; Tziotis, D; Witte, M | 1 |
| Kronberg, E; Legget, KT; Smucny, J; Tregellas, JR; Wylie, KP | 1 |
| Edmonds, SA; Freedman, R; Gee, KW; Harris, J; Hogenkamp, D; Johnson, L; Johnstone, T; Kanner, R; Olincy, A; Sauer, W; Tran, M; Yoshimura, R | 1 |
| Kenny, PJ; Liu, XA | 1 |
| Barr, RS; Evins, AE; Goff, DC; Jubelt, LE; Logvinenko, T; Weiss, AP | 1 |
| Adolfo, AB; Kaplan, GB; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
| Araki, H; Kohnomi, S; Suemaru, K; Umeda, K | 1 |
| Arends, MA; Fowler, CD; Kenny, PJ | 1 |
| Barr, RS; Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Dickerson, FB; Monson, ET; Origoni, AE; Severance, EG; Stallings, CR; Sullens, A; Yolken, RH | 1 |
| Araki, H; Choshi, T; Hibino, S; Kawasaki, H; Kohnomi, S; Suemaru, K | 1 |
| Cornwell, J; Davis, JM; Gupta, S; Lajtha, A; Lindenmayer, JP; Noth, K; Sershen, H; Smith, RC | 1 |
| Conway, JL | 1 |
| Bertrand, D; D'hoedt, D | 1 |
| Gandhi, KK; Williams, JM | 1 |
| George, TP; Rabin, RA; Sacco, KA | 1 |
| Berger, R; Freedman, R; Leonard, S; Logel, J; Mexal, S; Ross, RG | 1 |
| Buchholz, B; Hong, LE; Ross, TJ; Salmeron, BJ; Schroeder, M; Stein, EA; Thaker, GK; Wonodi, I | 1 |
| Winterer, G | 1 |
| Costa, E; Davis, JM; Guidotti, A; Lajtha, A; Maloku, E; Sershen, H; Smith, RC; Zhubi, A | 1 |
| Budsock, PD; Gandhi, KK; Steinberg, ML; Stipelman, B; Williams, JM; Ziedonis, DM; Zimmermann, MH | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Benowitz, NL; Foulds, J; Gandhi, KK; Kipen, H; Kumar, S; Lu, SE; Shen, J; Williams, JM | 1 |
| Benowitz, NL; Gandhi, KK; Williams, JM | 1 |
| Dulude, L; Knott, VJ; Labelle, A | 1 |
| George, TP; Sacco, KA; Wing, VC | 1 |
| Adam, E; Allen, MH; Damsa, C; Debanné, M; Dickinson, LM; Lazignac, C | 1 |
| Braff, DL | 1 |
| Albert, P; Choueiry, J; Fisher, D; Knott, V; Millar, A; Smith, D | 1 |
| Schechter, MA | 1 |
| Benowitz, NL; Cottler, B; Gandhi, KK; Kumar, S; Lu, SE; Steinberg, ML; Williams, JM | 1 |
| Cascella, N; Chen, Y; Kano, S; Niwa, M; Nwulia, E; Sawa, A | 1 |
| Dent, G; Jaeger, J; Turetsky, BI; Zukin, SR | 1 |
| George, TP; Soh, DW; Wass, CE; Wing, VC | 1 |
| Ferrea, S; Henning, U; Luckhaus, C; Mobascher, A; Musso, F; Winterer, G | 1 |
| Aggen, SH; Anton, R; Brunzell, DH; Chen, J; Chen, X; Damaj, I; Farrer, LA; Gejman, P; Gelernter, J; Holmans, P; Jackson, K; Kendler, KS; Kranzler, HR; Kuo, PH; Levinson, DF; Li, MD; Ma, JZ; Payne, TJ; Sherva, R; van der Vaart, A; Webb, BT | 1 |
| Borracci, G; Fisher, DJ; Grant, B; Knott, VJ; Labelle, A; Smith, DM | 1 |
| Gillberg, C; Hallerbäck, MU; Lugnegård, T | 1 |
| Clementino, KJ; Goel, A; Hall, AW; Jacklin, DL; Talpos, JC; Winters, BD | 1 |
| Ahn, K; Bhakta, S; D'Souza, DC; Elander, J; Jatlow, P; Nadim, H; Pittman, B; Ranganathan, M; Singh, N; Suckow, RF | 1 |
| Chen, HK; Lan, TH; Wu, BJ | 1 |
| Farhang, S; Farnam, A; Ghiasi, F; Safikhanlou, S | 1 |
| Brown, RW; Cope, ZA; Kostrzewa, RM; Maple, AM; Perna, MK; Sheppard, AB | 1 |
| Fukui, A; Hall, FS; Kasahara, Y; Sora, I; Uchiumi, O; Uhl, GR | 1 |
| Benowitz, NL; Gandhi, KK; Lu, SE; Steinberg, ML; Williams, JM | 1 |
| Buffalari, DM; Donny, EC; Joel, D; LeSage, MG; Levin, M; Sved, AF; Taylor, TG | 1 |
| Hong, LE; Moran, LV; Sampath, H; Stein, EA | 1 |
| Brinkmeyer, J; Drusch, K; Fisahn, K; Lowe, A; Mobascher, A; Musso, F; Ohmann, C; Shah, J; Warbrick, T; Winterer, G; Wölwer, W | 1 |
| Brinkmeyer, J; Jon Shah, N; Mobascher, A; Musso, F; Stoecker, T; Warbrick, T; Winterer, G | 1 |
| Dahmen, N; Drees, J; Ettinger, U; Frommann, I; Heilmann, K; Kessler, H; Landsberg, MW; Lennertz, L; Maier, W; Mössner, R; Petrovsky, N; Quednow, BB; Sträter, B; Wagner, M | 1 |
| Becker, KG; Kane, JK; Konu, O; Li, MD | 1 |
| Gulliver, SB; Hitsman, B; McChargue, DE | 1 |
| Infante, M; Khandat, A; Kloos, A; Singh, A; Smith, RC | 1 |
| Higgins, ST; O'Neill, SC; Tidey, JW | 1 |
| Addy, N; Levin, ED | 1 |
| Kamaraju, L; McEvoy, JP; Nelson, L; Wilson, W; Yang, YK | 1 |
| Bar, JL; Eisen, SA; Faraone, SV; Goldberg, J; Kremen, WS; Lyons, MJ; Toomey, R; Tsuang, M | 1 |
| Atkinson, V; Dépatie, L; Holahan, AL; Kin, NN; Lal, S; O'Driscoll, GA; Thavundayil, JX | 1 |
| Johnson, LL; Olincy, A; Ross, RG | 1 |
| Allen, TB; McEvoy, JP | 1 |
| Avila, MT; Hong, E; Myers, CS; Sherr, JD; Thaker, GK | 1 |
| BELUFFI, M | 1 |
| Court, JA; Davis, KL; Haroutunian, VH; Long, P; Martin-Ruiz, CM; Perry, EK; Young, AH | 1 |
| Chen, R; Chou, KR; Ku, CH; Lee, JF; Lu, RB | 1 |
| Gill, K; Malchy, L; Margolese, HC; Negrete, JC; Tempier, R | 1 |
| Patel, K; Procyshyn, RM; Thompson, DL | 1 |
| Markou, A; Spielewoy, C | 1 |
| Avila, MT; Blaxton, TA; Kakoyannis, AN; Myers, CS; Robles, O; Sherr, JD; Thaker, GK | 1 |
| D'Souza, DC; Jacobsen, LK; Krystal, JH; Mencl, WE; Pugh, KR; Skudlarski, P | 1 |
| Allensworth, D; Freedman, R; Harris, JG; Kongs, S; Martin, L; Sullivan, B; Tregellas, J; Zerbe, G | 1 |
| Els, C | 1 |
| Davidson, M; Grotto, I; Knobler, HY; Lubin, G; Nahon, D; Rabinowitz, J; Reichenberg, A; Weiser, M; Yasvitzky, R | 1 |
| Bagnall, AM; McIntosh, HM; Woolacott, NF | 1 |
| Bourin, M; Bronnec, M; Ripoll, N | 1 |
| Freedman, R; Martin, LF; Tanabe, JL; Tregellas, JR | 1 |
| Gur, RE; Kanes, SJ; Lerman, C; Liang, Y; Majumdar, S; Maxwell, CR; Siegel, SJ; Trief, DF | 1 |
| Dudas, MM; George, TP; Jatlow, PI; Krishnan-Sarin, S; Sacco, KA; Seyal, A; Termine, A; Vessicchio, JC; Wexler, BE | 1 |
| Abanyie, F; Benowitz, NL; Foulds, J; Steinberg, ML; Williams, JM; Ziedonis, DM | 1 |
| Kumari, V; Postma, P | 1 |
| Butler, E; Kelly, E; Khan, A; Matute, M; Smith, RC; Vaidhyanathaswamy, S; Warner-Cohen, J | 1 |
| Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Levin, ED; McClernon, FJ; Rezvani, AH | 1 |
| Freedman, R; Martin, LF; Tanabe, J; Tregellas, JR | 1 |
| Belgamwar, MR; Punnoose, S | 1 |
| Kuehn, BM | 1 |
| Das, M; Geyer, M; Gray, JA; Hines, M; Kumari, V; Mehrotra, R; Postma, P; Sharma, T; Williams, SC; Zachariah, E | 1 |
| Cakin Memik, N; Tural, U; Uneri, O | 1 |
| Ebner, N; Fischer, G; Sachs, G; Thau, K; Winklbaur, B | 1 |
| Bitner, RS; Bratcher, NA; Decker, MW; Gopalakrishnan, M; Miner, HM; Radek, RJ | 1 |
| Aasen, I; Kumari, V; Reed, C; Sharma, T | 1 |
| Allen, TM; Duncan, EJ; George, TP; Reutenauer, E; Sacco, KA; Termine, A; Vessicchio, JC | 1 |
| Brar, JS; Ganguli, R; Strassnig, M | 1 |
| Allen, TM; Easton, CJ; George, TP; McKee, SA; Reutenauer, EL; Sacco, KA; Termine, A; Vessicchio, JC; Weinberger, AH | 1 |
| Levin, ED; Rezvani, AH | 3 |
| Adams, CE; Leonard, S | 1 |
| Ehrlichman, RS; Phillips, JM; Siegel, SJ | 1 |
| Foulds, J; Williams, JM | 1 |
| Baker, A; Carr, VJ; Constable, PM; Haile, M; Jansons, S; Lewin, TJ; Moeller-Saxone, K; Richmond, R; Taylor, RL; Wilhelm, K | 1 |
| Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Caldwell, DP; Levin, ED; Perraut, C | 1 |
| Cadenhead, KS; Kristensen, K | 1 |
| Lasalde-Dominicci, J; Ochoa, EL | 1 |
| Birnbaum, A; Cather, C; Culhane, MA; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Horowitz, J; Hsieh, E; Rigotti, NA; Schoenfeld, DA | 1 |
| Benowitz, NL; Foulds, J; Gandhi, KK; Steinberg, ML; Williams, JM; Ziedonis, DM | 1 |
| Brown, GG; Eyler, LT | 1 |
| AhnAllen, CG; McCarley, RW; Nestor, PG; Niznikiewicz, MA; Shenton, ME | 1 |
| Hong, LE; Lewis, J; Thaker, GK; Wonodi, I | 1 |
| Arai, H; Inami, R; Inoue, R; Kirino, E; Suzuki, T | 1 |
| Allen, TM; Creeden, CL; Dudas, MM; Feingold, A; George, TP; Jatlow, PI; Potenza, MN; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Tizabi, Y | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Berg, SA; Chambers, RA | 1 |
| Deviney, S; Hamera, E; Schneider, JK | 1 |
| Meltzer, J; Rose, GM; Stevens, KE | 1 |
| Freudenreich, O; Levin, ED; McEvoy, JP; Rose, JE | 1 |
| Gilbert, BO; Gilbert, DG | 1 |
| Frances, RJ; Glazer, WM; Kosten, TR; Ziedonis, DM | 1 |
| Adler, LE; Freedman, R; Hoffer, LD; Wiser, A | 1 |
| Glassman, AH | 1 |
| Erdmann, R | 1 |
| Levin, ED; McEvoy, J; Rose, JE; Wilson, W | 1 |
| Chambers, RA; Levin, ED; McEvoy, JP; Moore, J | 1 |
| Dalack, GW; Meador-Woodruff, JH | 2 |
| Donnelly, CL; McEvoy, JP; Narasimhachari, N; Wilson, WH | 1 |
| Freedman, R; Olincy, A; Young, DA | 1 |
| Lindstrom, J | 1 |
| Freedman, R; Garver, D; Griffith, JM; O'Neill, JE; Petty, F; Young, D | 1 |
| Addington, J | 1 |
| Oyewumi, LK | 1 |
| Dalack, GW; Healy, DJ; Meador-Woodruff, JH | 1 |
| Deutsch, SI; Mastropaolo, J; Park, CH; Powell, D; Riggs, RL; Rosse, RB; Tizabi, Y | 1 |
| Chatterton, R; Plant, K; Sanderson, L; Van Leent, S | 1 |
| D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL | 1 |
| Dursun, SM; Kutcher, S | 1 |
| Adler, LE; Freedman, R; Olincy, A; Ross, RG; Waldo, MC | 1 |
| Freudenreich, O; McEvoy, JP; Wilson, WH | 1 |
| Becks, L; Dalack, GW; Hill, E; Meador-Woodruff, JH; Pomerleau, OF | 1 |
| Brus, R; Copeland, RL; Kostrzewa, RM; Tizabi, Y | 1 |
| Ballard, C; Cairns, N; Court, J; Kerwin, R; Lloyd, S; McKeith, I; Perry, E; Perry, R; Spurden, D | 1 |
| Lyon, ER | 1 |
| Hildebrand, BE; Svensson, TH | 1 |
| Adams, C; Adler, L; Benhammou, K; Breese, C; Freedman, R; Gault, J; Lee, M; Leonard, S; Olincy, A; Ross, R; Stevens, K | 1 |
| Adler, LE; Cawthra, E; Freedman, R; Harris, JG; McAndrews, MA; McRae, KA; Olincy, A; Ross, RG; Sullivan, B; Young, DA | 1 |
| Ballard, CG; Cookson, N; Court, JA; Lloyd, S; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA | 1 |
| Adams, CE; Breese, CR; Collins, AC; Gillen, KM; Lee, MJ; Leonard, S; Logel, J; Marks, MJ; Sullivan, B | 1 |
| Arun, P; Deepadevi, KV; Kurup, PA; Manojkumar, V; Ravikumar, A | 1 |
| Bright, JL; Mirza, NR; Misra, A | 1 |
| Feingold, A; George, TP; Kosten, TR; Pepper, WT; Rounsaville, BJ; Satterburg, CA; Winkel, J; Ziedonis, DM | 1 |
| Braff, DL; Light, GA | 1 |
| Breese, CR; Lee, MJ; Leonard, S; Strook, ML | 1 |
| Drucker-Colín, R; Mihailescu, S | 1 |
| Lodge, D | 1 |
| Ross, BM; Seeman, M; Turenne, SD | 1 |
| Hiemke, C; Modai, I; Rao, ML; Ritsner, M; Shlomo, N; Silver, H | 1 |
| Araki, H; Gomita, Y; Suemaru, K | 1 |
| Himmelhoch, JM; Horn, TL; Neil, JF | 1 |
| Flynn, K; Lohr, JB | 1 |
| Adler, LE; Freedman, R; Griffith, J; Hoffer, LJ; Waldo, MC | 1 |
| Greeman, M; McClellan, TA | 1 |
| David, JJ; Peach, MJ; Rowe, WT; Spradlin, WW; Veldhuis, JD; Vieweg, WV | 1 |
| Ally, J; Korpassy, A; Lal, S; Yassa, R | 1 |
59 review(s) available for nicotine and Schizophrenia
| Article | Year |
|---|---|
Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis.
Topics: Antipsychotic Agents; Clozapine; Female; Humans; Male; Nicotine; Observational Studies as Topic; Schizophrenia; Substance-Related Disorders | 2023 |
Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies.
Topics: Cannabis; Hallucinogens; Humans; Marijuana Abuse; Nicotine; Observational Studies as Topic; Schizophrenia | 2020 |
The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review.
Topics: Cognition; Humans; Neuropsychological Tests; Nicotine; Schizophrenia; Sensation | 2020 |
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Network Meta-Analysis; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2020 |
Smoking in Schizophrenia: an Updated Review.
Topics: Humans; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2018 |
Modeling nicotine regulation: A review of studies in smokers with mental health conditions.
Topics: Behavior, Addictive; Cigarette Smoking; Humans; Male; Mental Disorders; Mood Disorders; Nicotine; Schizophrenia; Smokers; Tobacco Use Disorder; United States | 2018 |
Smoking in schizophrenia: recent findings about an old problem.
Topics: Antipsychotic Agents; Epigenesis, Genetic; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2019 |
[Stopping and reducing smoking in patients with schizophrenia].
Topics: Bupropion; Cognitive Behavioral Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Schizophrenia; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2019 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2013 |
The impact of smoking cessation on schizophrenia and major depression.
Topics: Depressive Disorder, Major; Humans; Nicotine; Recurrence; Schizophrenia; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
[The nicotine receptor as target for the improvement of cognitive symptoms in schizophrenia].
Topics: Cognition; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia | 2013 |
Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.
Topics: Animals; Cognition Disorders; Endophenotypes; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia; Tobacco Use Disorder | 2014 |
Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Topics: Alcoholism; Brain; Caffeine; Central Nervous System Stimulants; Cognition; Comorbidity; Diagnosis, Dual (Psychiatry); Humans; Marijuana Abuse; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Social Environment; Substance-Related Disorders | 2013 |
α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention; Benzylidene Compounds; Cognition; Eye Movements; Fetal Development; Humans; Memory; Nicotine; Nicotinic Agonists; Pyridines; Schizophrenia; Sensory Gating; Smoking | 2014 |
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.
Topics: Brain; Cognition Disorders; Evoked Potentials; Humans; Nicotine; Nicotinic Agonists; Nootropic Agents; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking | 2014 |
The Role of Nicotine in Schizophrenia.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Electroencephalography; Evoked Potentials; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia | 2015 |
[Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Humans; Mice; Nicotine; Physical Stimulation; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2008 |
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Genetically Modified; Anxiety Disorders; Arousal; Comorbidity; Depressive Disorder; Genotype; Humans; Mice; Mice, Knockout; Nicotine; Phenotype; Receptors, Nicotinic; Reward; Schizophrenia; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
[Nicotinic acetylcholine receptors are possible therapeutic targets for schizophrenia].
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antiemetics; Disease Models, Animal; Dopamine; Gait Disorders, Neurologic; Humans; Indoles; Neural Inhibition; Nicotine; Rats; Receptors, Nicotinic; Schizophrenia; Serotonin Antagonists; Stereotyped Behavior; Tropisetron | 2009 |
Nicotinic acetylcholine receptors: an overview on drug discovery.
Topics: Allosteric Regulation; Analgesics; Bridged Bicyclo Compounds, Heterocyclic; Cardiovascular Diseases; Drug Discovery; Hearing; Humans; Myasthenia Gravis; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Protein Subunits; Psoriasis; Pyridines; Receptors, Nicotinic; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Use of caffeine and nicotine in people with schizophrenia.
Topics: Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Brain; Caffeine; Comorbidity; Cross-Sectional Studies; Cytochrome P-450 CYP2A6; Drug Interactions; Gene Expression; Humans; Neurotransmitter Agents; Nicotine; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Tobacco Use Disorder | 2008 |
Why do patients with schizophrenia smoke?
Topics: Adaptation, Psychological; Cognition Disorders; Ganglionic Stimulants; Humans; Neurocalcin; Nicotine; Prevalence; Psychological Theory; Receptors, Cholinergic; Reinforcement, Psychology; Schizophrenia; Self Medication; Signal Transduction; Smoking | 2010 |
Cognitive effects of nicotine: genetic moderators.
Topics: Animals; Brain; Catechol O-Methyltransferase; Cognition; Humans; Memory, Short-Term; Mice; Mice, Knockout; Nicotine; Receptors, Dopamine; Receptors, Nicotinic; Schizophrenia; Serotonin Plasma Membrane Transport Proteins; Smoking; Tobacco Use Disorder | 2010 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention | 2010 |
A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia.
Topics: Animals; Comorbidity; Corpus Striatum; Hippocampus; Humans; Neurons; Nicotine; Prefrontal Cortex; Receptors, Nicotinic; Risk Factors; Schizophrenia; Schizophrenic Psychology; Tobacco Use Disorder | 2012 |
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model.
Topics: Animals; Behavior, Addictive; Disease Models, Animal; Nicotine; Quinpirole; Schizophrenia; Tobacco Use Disorder | 2012 |
Impact of tobacco regulation on animal research: new perspectives and opportunities.
Topics: Animal Experimentation; Animals; Comorbidity; Disease Models, Animal; Dose-Response Relationship, Drug; Government Regulation; Humans; Nicotiana; Nicotine; Rodentia; Schizophrenia; Self Administration; Smoking Cessation; Tobacco Industry; Tobacco Products; Tobacco Use Disorder; United States | 2012 |
Microarray technology and its application on nicotine research.
Topics: Animals; Brain Chemistry; Gene Expression; Humans; Neuroprotective Agents; Nicotine; Oligonucleotide Array Sequence Analysis; Schizophrenia; Signal Transduction; Tobacco Use Disorder | 2002 |
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
Topics: Drug Interactions; Ganglionic Stimulants; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2002 |
The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome.
Topics: Bipolar Disorder; Cholinergic Agents; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia; Smoking; Tourette Syndrome | 2002 |
Nicotinic receptors and schizophrenia.
Topics: Cognition; Humans; Incidence; Neurotransmitter Agents; Nicotiana; Nicotine; Polymorphism, Genetic; Receptors, Nicotinic; Schizophrenia; Sensation; Smoking | 2004 |
Nicotine use in schizophrenia: the self medication hypotheses.
Topics: Animals; Humans; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Self Medication | 2005 |
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amygdala; Animals; Attention; Cognition; Hippocampus; Humans; Learning; Memory; Mice; Nicotine; Rats; Receptors, Nicotinic; Schizophrenia | 2006 |
Nicotine for schizophrenia.
Topics: Antipsychotic Agents; Humans; Nicotine; Schizophrenia | 2006 |
[Smoking and schizophrenia: where is the biological connection?].
Topics: Humans; Nicotine; Receptors, Dopamine; Schizophrenia; Smoking | 2006 |
Substance abuse in patients with schizophrenia.
Topics: Cannabis; Cocaine; Humans; Nicotine; Schizophrenia; Substance-Related Disorders | 2006 |
Nicotinic-antipsychotic drug interactions and cognitive function.
Topics: Animals; Antipsychotic Agents; Cognition; Drug Interactions; Humans; Nicotine; Schizophrenia | 2006 |
Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
Topics: Cognition; Cognition Disorders; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia; Smoking | 2007 |
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
Topics: Animals; Antipsychotic Agents; Cognition; Cognition Disorders; Drug Interactions; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia | 2007 |
Methodological and conceptual issues in functional magnetic resonance imaging: applications to schizophrenia research.
Topics: Bionics; Biophysics; Brain; Caffeine; Cerebral Cortex; Forecasting; Humans; Magnetic Resonance Imaging; Nicotine; Oxygen; Schizophrenia | 2006 |
Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.
Topics: Animals; Disease Models, Animal; Electrophysiology; Glutamic Acid; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Smoking | 2007 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
Personality, psychopathology, and nicotine response as mediators of the genetics of smoking.
Topics: Adaptation, Psychological; Anxiety; Depressive Disorder; Drug Tolerance; Extraversion, Psychological; Humans; Mental Disorders; Models, Psychological; Neurotic Disorders; Nicotine; Personality; Psychotic Disorders; Schizophrenia; Self Medication; Smoking; Social Class; Substance-Related Disorders | 1995 |
Nicotine dependence and schizophrenia.
Topics: Adult; Antipsychotic Agents; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Cigarette smoking: implications for psychiatric illness.
Topics: Adolescent; Brain Chemistry; Comorbidity; Depressive Disorder; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 1993 |
[Neuroleptics and nicotine].
Topics: Antipsychotic Agents; Brain; Dyskinesia, Drug-Induced; Humans; Nicotine; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, GABA; Receptors, Glutamate; Schizophrenia; Schizophrenic Psychology; Smoking | 1995 |
Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature.
Topics: Adult; Arousal; Chronic Disease; Dopamine; Humans; Male; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 1996 |
Nicotinic acetylcholine receptors in health and disease.
Topics: Acetylcholine; Alzheimer Disease; Anesthetics; Animals; Autoimmune Diseases; Cholinergic Agents; Cholinergic Antagonists; Epilepsy; Ethanol; Female; Keratinocytes; Male; Models, Molecular; Muscle Proteins; Myasthenia Gravis; Nerve Tissue Proteins; Neuromuscular Junction; Nicotine; Parkinson Disease; Pregnancy; Protein Conformation; Receptors, Nicotinic; Schizophrenia; Smoking; Torpedo; Tourette Syndrome | 1997 |
Group treatment for smoking cessation among persons with schizophrenia.
Topics: Behavior Therapy; Cholinergic Agents; Humans; Motivation; Nicotine; Ontario; Outcome Assessment, Health Care; Program Evaluation; Psychotherapy, Group; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Disorder; United States | 1998 |
Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
Topics: Adult; Animals; Bungarotoxins; Comorbidity; Dopamine; Drug Interactions; Glutamic Acid; Humans; Ion Channel Gating; Middle Aged; Models, Biological; Models, Neurological; Nicotine; Prevalence; Rats; Receptors, Dopamine; Receptors, Glutamate; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Tobacco Use Disorder | 1998 |
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Dopamine; Health Care Costs; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1999 |
Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
Topics: Acetylcholine; Anxiety Disorders; Dopamine; Ethics, Medical; Humans; Mental Disorders; Models, Neurological; Mood Disorders; Nicotine; Norepinephrine; Psychopharmacology; Receptors, Nicotinic; Schizophrenia; Serotonin; Smoking; Tourette Syndrome | 1999 |
Elementary phenotypes in the neurobiological and genetic study of schizophrenia.
Topics: Attention; Brain; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Evoked Potentials, Auditory; Genetic Linkage; Humans; Nicotine; Phenotype; Receptors, Cholinergic; Receptors, Nicotinic; Risk Factors; Saccades; Schizophrenia; Synaptic Transmission | 1999 |
A review of the effects of nicotine on schizophrenia and antipsychotic medications.
Topics: Antipsychotic Agents; Auditory Perception; Chlorpromazine; Chronic Disease; Clozapine; Databases as Topic; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Humans; Nicotine; Nucleus Accumbens; Prefrontal Cortex; Schizophrenia; Severity of Illness Index; Smoking Cessation | 1999 |
[New possibilities in pharmacological treatment of nicotine dependence].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Humans; Nicotine; Rats; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Human and animal studies of schizophrenia-related gating deficits.
Topics: Animals; Disease Models, Animal; Evoked Potentials, Auditory; Ganglionic Stimulants; Humans; Mental Processes; Nicotine; Rats; Reflex, Startle; Schizophrenia; Social Isolation | 1999 |
Nicotine and brain disorders.
Topics: Alzheimer Disease; Animals; Attention Deficit Disorder with Hyperactivity; Humans; Nicotine; Parkinson Disease; Receptors, Nicotinic; Schizophrenia | 2000 |
Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Humans; Mental Disorders; Nicotine; Receptors, Nicotinic; Schizophrenia; Substance Withdrawal Syndrome | 2002 |
Smoking and schizophrenia.
Topics: Antipsychotic Agents; Dopamine; Dyskinesia, Drug-Induced; Humans; Nicotine; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Smoking | 1992 |
58 trial(s) available for nicotine and Schizophrenia
| Article | Year |
|---|---|
Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot study.
Topics: Adult; Cognitive Remediation; Double-Blind Method; Executive Function; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Pilot Projects; Quality of Life; Schizophrenia; Schizophrenic Psychology; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2019 |
Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.
Topics: Adolescent; Adult; Attention; Case-Control Studies; Caudate Nucleus; Cognition; Cross-Over Studies; Female; Gyrus Cinguli; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Middle Aged; Motor Activity; Nicotine; Nicotinic Agonists; Pilot Projects; Prefrontal Cortex; Reaction Time; Schizophrenia; Young Adult | 2018 |
Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Bupropion; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Middle Aged; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
Topics: Acoustic Stimulation; Adult; Brain; Double-Blind Method; Evoked Potentials; Evoked Potentials, Auditory; Healthy Volunteers; Humans; Nicotine; Nicotinic Agonists; Schizophrenia; Sensory Gating; Young Adult | 2013 |
Pilot study of intravenous nicotine effects on cognitive performance in schizophrenia.
Topics: Cognition Disorders; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 2013 |
The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?
Topics: Adult; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Linear Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Nootropic Agents; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking | 2014 |
Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial.
Topics: Administration, Inhalation; Analysis of Variance; Chi-Square Distribution; Clinical Protocols; Cognition; Electronics; Equipment Design; Humans; Italy; Nicotine; Nicotinic Agonists; Patient Satisfaction; Perception; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Volatilization | 2014 |
Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.
Topics: Adult; Cognition; Female; Humans; Male; Memory, Short-Term; Middle Aged; Nicotiana; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2015 |
The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Evoked Potentials; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Nicotine; Schizophrenia; Sensory Gating; Smoking; Tobacco Use Cessation Devices | 2015 |
Neuronal effects of nicotine during auditory selective attention in schizophrenia.
Topics: Acoustic Stimulation; Adult; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Brain; Brain Mapping; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reaction Time; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Treatment Outcome | 2016 |
Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.
Topics: Adult; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2016 |
Nicotine restores functional connectivity of the ventral attention network in schizophrenia.
Topics: Acoustic Stimulation; Adult; Attention; Brain; Cross-Over Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Nicotine; Psychomotor Performance; Schizophrenia; Single-Blind Method; Tobacco Use Cessation Devices | 2016 |
Nicotinic modulation of salience network connectivity and centrality in schizophrenia.
Topics: Adult; Analysis of Variance; Blood Pressure; Brain; Brain Mapping; Case-Control Studies; Female; Heart Rate; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Neural Pathways; Nicotine; Nicotinic Agonists; Oxygen; Psychiatric Status Rating Scales; Schizophrenia; Single-Blind Method; Statistics as Topic; Tobacco Use Cessation Devices | 2017 |
First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288.
Topics: Adult; Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Anilides; Biomarkers; Cognition; Double-Blind Method; Female; Humans; Isoxazoles; Male; Neurocognitive Disorders; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Schizophrenia; Synaptic Transmission; Young Adult | 2017 |
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.
Topics: Administration, Cutaneous; Adult; Arousal; Attention; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Nicotine; Psychotic Disorders; Reaction Time; Schizophrenia; Schizophrenic Psychology; Verbal Learning | 2008 |
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzazepines; Carbon Dioxide; Cognition; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking; Time Factors; Varenicline | 2009 |
Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.
Topics: Administration, Cutaneous; Adult; Attention; Brain; Brain Mapping; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Nicotine; Nicotinic Agonists; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Schizophrenia; Smoking | 2011 |
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Combined Modality Therapy; Directive Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychotic Disorders; Schizophrenia; Secondary Prevention; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2010 |
Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking | 2010 |
Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia.
Topics: Acoustic Stimulation; Adult; Auditory Perception; Double-Blind Method; Humans; Male; Memory Disorders; Nicotine; Schizophrenia; Smoking | 2010 |
Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Transdermal Patch; Violence; Young Adult | 2011 |
The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.
Topics: Adolescent; Adult; Brain; Cross-Over Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Evoked Potentials, Auditory; Female; Genotype; Humans; Male; Nicotine; Nicotinic Agonists; Polymerase Chain Reaction; Schizophrenia; Sensory Gating; Young Adult | 2011 |
P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
Topics: Adolescent; Adult; Evoked Potentials, Auditory; Family; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Schizophrenia; Sensory Gating; Smoking; Substance Withdrawal Syndrome | 2012 |
Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.
Topics: Adult; Binding Sites; Down-Regulation; Female; Humans; Male; Middle Aged; Nicotine; Precursor Cells, B-Lymphoid; Primary Cell Culture; Receptors, Nicotinic; Schizophrenia; Smoking; Young Adult | 2012 |
Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
Topics: Acoustic Stimulation; Adult; Blood Pressure; Brain; Contingent Negative Variation; Cross-Sectional Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Hallucinations; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia | 2012 |
Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
Topics: Adolescent; Adult; Attention; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Drug Interactions; Executive Function; Humans; Inhibition, Psychological; Ketamine; Memory; Middle Aged; Motor Skills; Nicotine; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time; Recognition, Psychology; Schizophrenia | 2012 |
A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
The short term effect of nicotine abstinence on visuospatial working memory in smoking patients with schizophrenia.
Topics: Adult; Ganglionic Stimulants; Humans; Male; Memory, Short-Term; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Space Perception; Tobacco Use Cessation Devices; Visual Perception; Young Adult | 2013 |
Insular and anterior cingulate circuits in smokers with schizophrenia.
Topics: Adolescent; Adult; Brain Mapping; Cross-Over Studies; Double-Blind Method; Female; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Oxygen; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Young Adult | 2012 |
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.
Topics: Adult; Analysis of Variance; Cognition Disorders; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Self Report; Smoking; Social Behavior; Statistics as Topic; Stress, Psychological; Young Adult | 2013 |
Nicotine effects on anterior cingulate cortex in schizophrenia and healthy smokers as revealed by EEG-informed fMRI.
Topics: Adolescent; Adult; Analysis of Variance; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Schizophrenia; Smoking; Young Adult | 2012 |
Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cotinine; Cross-Over Studies; Double-Blind Method; Electrooculography; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reaction Time; Saccades; Schizophrenia; Smoking; Statistics as Topic; Young Adult | 2013 |
Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
Topics: Administration, Intranasal; Adult; Analysis of Variance; Blood Pressure; Cognition; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotine; Schizophrenia; Smoking; Treatment Outcome | 2002 |
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Breath Tests; Carbon Monoxide; Cotinine; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation | 2002 |
Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Anti-Dyskinesia Agents; Brain; Female; Haloperidol; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Nicotine; Schizophrenia; Smoking | 2002 |
Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study.
Topics: Adult; Analysis of Variance; Attention; Cross-Over Studies; Double-Blind Method; Eye Movements; Female; Humans; Male; Middle Aged; Nicotine; Psychomotor Performance; Risk Factors; Schizophrenia | 2002 |
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Female; Ganglionic Stimulants; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Patient Compliance; Prevalence; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2004 |
Nicotine improves delayed recognition in schizophrenic patients.
Topics: Adult; Analysis of Variance; Case-Control Studies; Female; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pattern Recognition, Visual; Psychomotor Performance; Schizophrenia; Smoking; Task Performance and Analysis | 2004 |
Nicotine effects on brain function and functional connectivity in schizophrenia.
Topics: Adult; Analysis of Variance; Attention; Brain; Brain Mapping; Brief Psychiatric Rating Scale; Case-Control Studies; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Reaction Time; Regression Analysis; Schizophrenia; Smoke; Task Performance and Analysis; Verbal Learning | 2004 |
Effects of nicotine on cognitive deficits in schizophrenia.
Topics: Adult; Attention; Chewing Gum; Cognition Disorders; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Schizophrenia; Single-Blind Method; Smoking; Time Factors; Verbal Behavior | 2004 |
FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia.
Topics: Adult; Area Under Curve; Brain; Female; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Nicotine; Nicotinic Agonists; Parietal Lobe; Psychomotor Performance; Pursuit, Smooth; Schizophrenia; Schizophrenic Psychology; Visual Pathways | 2005 |
Effects of nicotine nasal spray on cognitive function in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Blood Pressure; Carbon Monoxide; Cognition; Cotinine; Double-Blind Method; Female; Heart Rate; Humans; Linear Models; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Space Perception | 2006 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia.
Topics: Administration, Oral; Adult; Analysis of Variance; Cerebral Cortex; Double-Blind Method; Female; Ganglionic Stimulants; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Oxygen; Pursuit, Smooth; Schizophrenia | 2006 |
A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia.
Topics: Adult; Arousal; Attention; Brain; Cross-Over Studies; Double-Blind Method; Drug Synergism; Hippocampus; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Middle Aged; Neural Inhibition; Nicotine; Oxygen; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Smoking; Tobacco Use Disorder; Touch | 2006 |
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior | 2006 |
Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; New South Wales; Nicotine; Outcome and Process Assessment, Health Care; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Smoking; Smoking Cessation; Statistics as Topic; Tobacco Use Disorder; Victoria | 2007 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Sample Size; Schizophrenia; Schizophrenic Psychology; Smoking Cessation | 2007 |
Nicotine effects on mismatch negativity in nonsmoking schizophrenic patients.
Topics: Acoustic Stimulation; Administration, Cutaneous; Adult; Analysis of Variance; Area Under Curve; Case-Control Studies; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Nicotine; Nicotinic Agonists; Reaction Time; Schizophrenia; Time Factors | 2007 |
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2008 |
Nicotine-haloperidol interactions and cognitive performance in schizophrenics.
Topics: Adult; Antipsychotic Agents; Cognition; Drug Synergism; Female; Haloperidol; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Reaction Time; Schizophrenia | 1996 |
A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Diet; Drug Interactions; GABA Modulators; Homovanillic Acid; Humans; Lorazepam; Male; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 1996 |
Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
Topics: Acoustic Stimulation; Administration, Cutaneous; Adult; Double-Blind Method; Electroencephalography; Evoked Potentials; Evoked Potentials, Auditory; Female; Habituation, Psychophysiologic; Humans; Male; Nicotine; Placebos; Polysomnography; Receptors, Nicotinic; Schizophrenia; Sleep; Sleep, REM | 1998 |
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Prevalence; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antipsychotic Agents; Comorbidity; Female; Humans; Male; Nicotine; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2000 |
Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Consumer Product Safety; Cross-Over Studies; Double-Blind Method; Humans; Nicotine; Schizophrenia; Smoking Cessation; Tobacco Use Disorder | 1999 |
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.
Topics: Adult; Arousal; Attention; Chewing Gum; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Nicotine; Physostigmine; Receptors, Muscarinic; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted | 1992 |
120 other study(ies) available for nicotine and Schizophrenia
| Article | Year |
|---|---|
Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Locomotion; Male; Mice; Motor Activity; Nicotine; Phencyclidine; Recognition, Psychology; Schizophrenia; Sensory Gating | 2021 |
Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Hippocampus; Male; Methylazoxymethanol Acetate; Nicotine; Prepulse Inhibition; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Medication; Ventral Tegmental Area | 2021 |
Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia.
Topics: Craving; Double-Blind Method; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Schizophrenia; Smokers; Smoking; Substance Withdrawal Syndrome; Varenicline | 2022 |
Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.
Topics: China; Cognition; Demography; Humans; Male; Nicotine; Schizophrenia; Schizophrenic Psychology; Smokers; Smoking; Tobacco Use Disorder | 2022 |
Nicotine-conditioned place preference, reversal learning and social interaction in MK-801-induced schizophrenia model: Effects of post-weaning enriched environment.
Topics: Animals; Conditioning, Classical; Dizocilpine Maleate; Male; Maze Learning; Nicotine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reversal Learning; Schizophrenia; Social Interaction; Weaning | 2022 |
[Tobacco cessation treatment for people with schizophrenia].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
A pilot study of transdermal nicotine effects on facial emotion responding in non-smoking healthy controls and individuals with schizophrenia: Feasibility and effect size estimates.
Topics: Emotions; Facial Expression; Humans; Nicotine; Nicotinic Agonists; Pilot Projects; Schizophrenia; Schizophrenic Psychology | 2022 |
Recovery effect: Cigarette smoking acts on the neural dynamics of early auditory processing in schizophrenia.
Topics: Auditory Perception; Cigarette Smoking; Evoked Potentials, Auditory; Humans; Nicotine; Schizophrenia | 2023 |
Smoking status ameliorates cholinergic impairments in cortical inhibition in patients with schizophrenia.
Topics: Cholinergic Agents; Evoked Potentials, Motor; Humans; Motor Cortex; Neural Inhibition; Nicotine; Schizophrenia; Smoking; Transcranial Magnetic Stimulation | 2023 |
Acute effects of exercise among individuals with schizophrenia who smoke cigarettes.
Topics: Cigarette Smoking; Craving; Cues; Humans; Nicotine; Schizophrenia; Substance Withdrawal Syndrome; Tobacco Products | 2023 |
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice.
Topics: Animals; Disease Models, Animal; Female; Male; Mice; Nicotine; Phencyclidine; Prefrontal Cortex; Schizophrenia; Synaptic Transmission | 2023 |
Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cells, Cultured; Dependency, Psychological; Disease Models, Animal; Female; Humans; Male; Mice; Middle Aged; Nicotine; Nucleus Accumbens; Phencyclidine; Schizophrenia; Social Interaction | 2020 |
Convergent observations of MK-801-induced impairment in rat 5C-CPT performance across laboratories: reversal with a D
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Attention; Cognition; Dizocilpine Maleate; Dopamine Agonists; Laboratories; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Schizophrenia | 2021 |
A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes.
Topics: Adult; Electronic Nicotine Delivery Systems; Feasibility Studies; Female; Humans; Male; Nicotine; Pilot Projects; Schizophrenia; Smoke; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2021 |
Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Nicotine; Olanzapine; Practice Guidelines as Topic; Schizophrenia; Substance-Related Disorders | 2022 |
Acquisition of nicotine self-administration in amphetamine and phencyclidine models of schizophrenia: A role for stress?
Topics: Amphetamine; Animals; Disease Models, Animal; Learning; Male; Motor Activity; Nicotine; Nicotinic Agonists; Phencyclidine; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Self Administration; Stress, Psychological; Tobacco Use Disorder | 2018 |
A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Clozapine; Conditioning, Classical; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Schizophrenia | 2017 |
Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cognition; Cognition Disorders; Female; Humans; Male; Models, Theoretical; Neuropsychological Tests; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation | 2018 |
Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia.
Topics: Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Female; Lipopolysaccharides; Male; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Self Administration | 2018 |
Neuregulin signaling pathway in smoking behavior.
Topics: Aged; Female; Finland; Genetic Linkage; Humans; Male; Middle Aged; Neuregulin-1; Neuregulins; Nicotine; Phenotype; Polymorphism, Single Nucleotide; Receptor, ErbB-4; Schizophrenia; Signal Transduction; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Twins, Dizygotic; Twins, Monozygotic | 2017 |
Effects of Environmental Enrichment on Nicotine Sensitization in Rats Neonatally Treated with Quinpirole: Analyses of Glial Cell Line-Derived Neurotrophic Factor and Implications towards Schizophrenia.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Dopamine Agonists; Female; Glial Cell Line-Derived Neurotrophic Factor; Housing, Animal; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinpirole; Rats; Schizophrenia; Substance-Related Disorders | 2018 |
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance.
Topics: Animals; Brain; Caffeine; Central Nervous System Agents; Cytoskeletal Proteins; Drug Interactions; Drug Resistance; Gene Expression; Haloperidol; Homer Scaffolding Proteins; Male; Motor Activity; Nerve Tissue Proteins; Nicotine; Post-Synaptic Density; Psychotic Disorders; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia | 2018 |
Chronic nicotine administration restores brain region specific upregulation of oxytocin receptor binding levels in a G72 mouse model of schizophrenia.
Topics: Animals; Brain; Disease Models, Animal; Female; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Nicotine; Protein Binding; Receptors, Oxytocin; Schizophrenia; Up-Regulation | 2019 |
Nicotine in action: cigarette smoking modulated homotopic functional connectivity in schizophrenia.
Topics: Adult; Cerebral Cortex; Cigarette Smoking; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Nicotine; Prefrontal Cortex; Schizophrenia | 2019 |
Polysubstance addiction vulnerability in mental illness: Concurrent alcohol and nicotine self-administration in the neurodevelopmental hippocampal lesion rat model of schizophrenia.
Topics: Alcoholism; Animals; Behavior, Animal; Disease Models, Animal; Ethanol; Hippocampus; Male; Nicotine; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Administration; Tobacco Use Disorder | 2020 |
Nicotine effect on mismatch negativity in smoking and nonsmoking patients with schizophrenia.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Case-Control Studies; Cigarette Smoking; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Nicotine; Nicotinic Agonists; Non-Smokers; Schizophrenia; Smokers; Tobacco Use Cessation Devices; Young Adult | 2019 |
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Cigarette Smoking; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Nicotine; Reinforcement Schedule; Reward; Schizophrenia; Schizophrenic Psychology; Signal Detection, Psychological; Tobacco Use Disorder; Young Adult | 2019 |
Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Methylazoxymethanol Acetate; Nicotine; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Schizophrenia; Self Administration; Sucrose | 2020 |
Temporal dynamic changes of intrinsic brain activity in schizophrenia with cigarette smoking.
Topics: Adult; Brain Mapping; Cigarette Smoking; Comorbidity; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Nicotinic Agonists; Parietal Lobe; Prefrontal Cortex; Schizophrenia | 2019 |
A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.
Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Substance Withdrawal Syndrome | 2013 |
Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia.
Topics: Antipsychotic Agents; Biomarkers; Humans; Ketamine; Magnetic Resonance Imaging; Nicotine; Risperidone; Schizophrenia | 2014 |
Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Carrier Proteins; Cognition; Disease Models, Animal; Drug Administration Schedule; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Memory, Short-Term; Mice; Mice, Transgenic; Neural Inhibition; Nicotine; Nicotinic Agonists; Nootropic Agents; Phenotype; Prosencephalon; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Social Behavior; Time Factors | 2014 |
Nicotine usage is associated with elevated processing speed, spatial working memory, and visual learning performance in youth at ultrahigh-risk for psychosis.
Topics: Adolescent; Cognition; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nicotine; Psychotic Disorders; Risk; Schizophrenia; Smoking; Spatial Learning; Spatial Memory; Young Adult | 2014 |
Peripheral DISC1 protein levels as a trait marker for schizophrenia and modulating effects of nicotine.
Topics: Animals; Brain; Cotinine; Female; Flow Cytometry; Gene Expression Regulation; Humans; Lymphocytes; Male; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Regression Analysis; Schizophrenia; Tobacco Use Disorder | 2014 |
Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.
Topics: Administration, Cutaneous; Age Factors; Animals; Animals, Newborn; Cognition; Disease Models, Animal; Female; Hippocampus; Male; Maze Learning; Nicotine; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Schizophrenia; Treatment Outcome | 2015 |
Small effects of smoking on visual spatiotemporal processing.
Topics: Adult; Female; Humans; Male; Nicotiana; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoke; Smoking; Spatio-Temporal Analysis; Vision, Ocular; Visual Cortex | 2014 |
The modulation of nicotinic acetylcholine receptors on the neuronal network oscillations in rat hippocampal CA3 area.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; CA3 Region, Hippocampal; Humans; Male; Neuronal Plasticity; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Receptors, Nicotinic; Schizophrenia | 2015 |
Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; Evoked Potentials, Auditory; Female; Gene Expression Regulation; Indoles; Male; Methylazoxymethanol Acetate; Neurodevelopmental Disorders; Nicotine; Pregnancy; Quinuclidines; Rats; Rats, Sprague-Dawley; Schizophrenia | 2015 |
Effects of the phencyclidine model of schizophrenia and nicotine on total and categorized ultrasonic vocalizations in rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Male; Nicotine; Phencyclidine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Schizophrenia; Smoking; Ultrasonics; Vocalization, Animal | 2016 |
Nicotine replacement therapy may ease agitation for hospitalized patients with schizophrenia.
Topics: Humans; Nicotine; Psychomotor Agitation; Schizophrenia | 2011 |
Prenatal Nicotine Exposure and Risk of Schizophrenia Among Offspring in a National Birth Cohort.
Topics: Adolescent; Adult; Case-Control Studies; Cohort Studies; Cotinine; Female; Finland; Humans; Nicotine; Odds Ratio; Pregnancy; Prenatal Exposure Delayed Effects; Registries; Risk Factors; Schizophrenia; Smoking; Statistics as Topic; Tobacco Use Disorder; Young Adult | 2016 |
Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats.
Topics: Animals; Cognition Disorders; Female; Lipopolysaccharides; Male; Maternal Exposure; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Rats, Sprague-Dawley; Schizophrenia | 2016 |
Nicotine-induced neuroplasticity counteracts the effect of schizophrenia-linked neuregulin 1 signaling on NMDAR function in the rat hippocampus.
Topics: Animals; Animals, Newborn; Neuregulin-1; Neuronal Plasticity; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Signal Transduction | 2017 |
Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Behavior, Animal; CRISPR-Cas Systems; Disease Models, Animal; Fluorescent Antibody Technique; Male; Mice; Mice, Knockout; Mice, Transgenic; Neural Inhibition; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Prefrontal Cortex; Prepulse Inhibition; Pyramidal Cells; Receptors, Adrenergic, beta-2; Receptors, Nicotinic; Reflex, Startle; Schizophrenia; Social Behavior; Tobacco Use Disorder | 2017 |
α5 nicotinic receptors link smoking to schizophrenia.
Topics: Animals; Models, Animal; Nicotine; Receptors, Nicotinic; Schizophrenia; Smoking | 2017 |
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cues; Female; Humans; Male; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2008 |
Predictors of early abstinence in smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Attention; Chewing Gum; Cognitive Behavioral Therapy; Female; Humans; Logistic Models; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Cessation Devices; United States | 2008 |
Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytes.
Topics: alpha7 Nicotinic Acetylcholine Receptor; C-Reactive Protein; Cotinine; Enzyme-Linked Immunosorbent Assay; Humans; Lymphocytes; Nicotine; Protein Isoforms; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Smoking; Transcription, Genetic | 2009 |
Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications.
Topics: Apoptosis; Humans; Nicotine; Schizophrenia; Smoking; Synaptic Transmission | 2009 |
Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.
Topics: Acoustic Stimulation; Adult; Analysis of Variance; Cotinine; Executive Function; Female; Humans; Male; Middle Aged; Neural Inhibition; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Reaction Time; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Smoking; Statistics as Topic; Time Factors | 2009 |
Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Autoradiography; Brain Chemistry; Cohort Studies; Down-Regulation; Female; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Hippocampus; Humans; Male; Middle Aged; Nicotine; Protein Transport; Radioligand Assay; Receptors, Nicotinic; Schizophrenia; Smoking | 2010 |
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
Topics: Benzazepines; Cotinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Gene Expression; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; RNA, Messenger; Schizophrenia; Smoking Cessation; Varenicline | 2010 |
Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Carbamazepine; Cotinine; Cytochrome P-450 CYP2A6; Enzyme Induction; Female; Humans; Male; Middle Aged; Nicotine; Oxcarbazepine; Schizophrenia; Smoking; Valproic Acid; Young Adult | 2010 |
Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia.
Topics: Humans; Mecamylamine; Memory Disorders; Memory, Short-Term; Neuropsychological Tests; Nicotine; Nicotinic Antagonists; Schizophrenia; Smoking; Smoking Cessation | 2011 |
Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia.
Topics: Antipsychotic Agents; Brain; Dopamine; Humans; Inhibition, Psychological; Nicotine; Reflex, Startle; Schizophrenia; Sensory Gating | 2010 |
Nicotine replacement therapy in the psychiatric emergency department.
Topics: Antipsychotic Agents; Emergency Service, Hospital; Humans; Nicotine; Psychiatric Department, Hospital; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Violence | 2011 |
Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.
Topics: Adult; Age Factors; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Sex Factors; Smoking; Surveys and Questionnaires | 2011 |
Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia.
Topics: Complement C1q; Complement C3; Down-Regulation; Gene Expression Regulation; Histocompatibility Antigens Class I; Humans; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Schizophrenia; Smoking | 2011 |
ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.
Topics: Adolescent; Adult; Aged; Animals; Coenzyme A Ligases; Environmental Exposure; Female; Gene Expression Regulation; Humans; Male; Mecamylamine; Mice; Middle Aged; Nicotine; Nicotinic Antagonists; Polymorphism, Single Nucleotide; Rats; Receptors, Nicotinic; RNA, Messenger; Schizophrenia; Smoking; Time Factors; Young Adult | 2011 |
ADHD and nicotine use in schizophrenia or Asperger syndrome: a controlled study.
Topics: Adult; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Comorbidity; Female; Humans; Male; Nicotine; Prevalence; Psychiatric Status Rating Scales; Schizophrenia; Surveys and Questionnaires; Tobacco Use Disorder | 2014 |
Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.
Topics: Animals; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Ketamine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Schizophrenia | 2012 |
Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
Topics: Animals; Behavior, Animal; Cognition Disorders; Crosses, Genetic; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Female; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Neural Inhibition; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Psychomotor Disorders; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2013 |
Nicotine intake and smoking topography in smokers with bipolar disorder.
Topics: Adult; Antimanic Agents; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Case-Control Studies; Cotinine; Cytochrome P-450 CYP2A6; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking | 2012 |
Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.
Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Maze Learning; Memory, Short-Term; Neural Pathways; Nicotine; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine; Risperidone; Schizophrenia | 2002 |
Nicotine and familial vulnerability to schizophrenia: a discordant twin study.
Topics: Adult; Diseases in Twins; Family; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Risk; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia.
Topics: Adult; Female; Humans; Inhibition, Psychological; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Saccades; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Smoking | 2003 |
Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia.
Topics: Adult; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Psychomotor Performance; Pursuit, Smooth; Saccades; Schizophrenia; Smoking | 2003 |
[Contribution to the study of experimental catatonia: experimental nicotine-induced catatonia].
Topics: Catatonia; Nicotine; Schizophrenia | 1952 |
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.
Topics: Aged; Aged, 80 and over; Bridged Bicyclo Compounds, Heterocyclic; Case-Control Studies; Cotinine; Dementia; Female; Humans; Male; Middle Aged; Nicotine; Prefrontal Cortex; Psychiatric Status Rating Scales; Pyridines; Radioligand Assay; Receptors, Nicotinic; RNA, Messenger; Schizophrenia; Severity of Illness Index; Smoking | 2003 |
Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Comorbidity; Cross-Sectional Studies; Demography; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 2004 |
Smoking, anticholinergics and schizophrenia.
Topics: Cholinergic Antagonists; Humans; Models, Neurological; Motivation; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking | 2004 |
Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients.
Topics: Animals; Disease Models, Animal; Hallucinogens; Humans; Male; Mice; Mice, Inbred Strains; Nicotine; Phencyclidine; Schizophrenia; Smoking Prevention; Species Specificity | 2004 |
What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
Topics: Administration, Cutaneous; Health Promotion; Humans; Nicotine; Schizophrenia; Smoking Cessation; Tobacco Use Disorder | 2004 |
Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study.
Topics: Adolescent; Adolescent Behavior; Adult; Cohort Studies; Confidence Intervals; Follow-Up Studies; Hospitalization; Humans; Israel; Male; Nicotine; Prevalence; Prospective Studies; Registries; Risk Factors; Schizophrenia; Sex Factors; Smoking | 2004 |
Assessing harmful effects in systematic reviews.
Topics: Anticonvulsants; Antipsychotic Agents; Bupropion; Delayed-Action Preparations; Humans; Meta-Analysis as Topic; Nicotine; Observation; Quality Control; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Schizophrenia; Smoking Cessation; Treatment Outcome | 2004 |
Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Bupropion; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Evoked Potentials, Auditory; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia | 2005 |
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
Topics: Adult; Attention; Behavior, Addictive; Cognition; Cognition Disorders; Comorbidity; Female; Humans; Male; Mecamylamine; Memory; Memory Disorders; Neuropsychological Tests; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Tobacco Use Disorder | 2005 |
Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.
Topics: Adult; Cotinine; Demography; Female; Humans; Male; Middle Aged; Nicotine; Psychotic Disorders; Regression Analysis; Schizophrenia; Smoking | 2005 |
Link between smoking and mental illness may lead to treatments.
Topics: Cognition; Humans; Mental Disorders; Nicotine; Schizophrenia; Smoking | 2006 |
Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.
Topics: Animals; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Hippocampus; Mecamylamine; Mental Processes; Mice; Mice, Inbred DBA; Nicotine; Receptors, Nicotinic; Schizophrenia | 2006 |
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.
Topics: Acetylcholinesterase; Adult; Double-Blind Method; Female; Ganglionic Stimulants; Habituation, Psychophysiologic; Humans; Male; Mecamylamine; Neural Inhibition; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia; Smoking; Surveys and Questionnaires | 2006 |
Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia.
Topics: Adult; Body Mass Index; Caffeine; Cross-Sectional Studies; Demography; Feeding Behavior; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Residence Characteristics; Schizophrenia; Schizophrenic Psychology; Smoking | 2006 |
Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia.
Topics: Adult; Comorbidity; Female; Humans; Male; Nicotine; Psychometrics; Reproducibility of Results; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Smoking cessation and schizophrenia.
Topics: Administration, Cutaneous; Animals; Hippocampus; Humans; Interneurons; Nicotine; Rats; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
Topics: Acetylcholine; Action Potentials; Animals; Biological Clocks; Brain; Cognition Disorders; Evoked Potentials, Auditory; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia; Synaptic Transmission; Tobacco Use Disorder | 2007 |
Successful tobacco dependence treatment in schizophrenia.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Chewing Gum; Comorbidity; Humans; Male; Nebulizers and Vaporizers; Nicotine; Prognosis; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response.
Topics: Animals; Antipsychotic Agents; Clozapine; Dizocilpine Maleate; Drug Interactions; Female; Humans; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia | 2007 |
Cannabis abuse and risk for psychosis in a prodromal sample.
Topics: Adolescent; Adult; Cannabinoids; Child; Disease Progression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Nicotine; Psychoses, Substance-Induced; Risk Assessment; Schizophrenia; Schizotypal Personality Disorder; Smoking; Statistics as Topic | 2007 |
Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia.
Topics: Adult; Analysis of Variance; Carbon Monoxide; Cotinine; Female; Flavoring Agents; Humans; Male; Menthol; Nicotine; Schizophrenia; Tobacco Use Disorder | 2007 |
Exacerbation of schizophrenia by varenicline.
Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline | 2007 |
Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia.
Topics: Administration, Cutaneous; Adolescent; Adult; Attention; Cognition Disorders; Comorbidity; Control Groups; Humans; Middle Aged; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Schizophrenia; Schizophrenic Psychology; Skin Absorption; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.
Topics: Acoustic Stimulation; Adult; Analysis of Variance; Chi-Square Distribution; Female; Humans; Inhibition, Psychological; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Reaction Time; Reflex, Acoustic; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2008 |
Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Hippocampus; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior | 2008 |
Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia.
Topics: Adult; Alcoholism; Antipsychotic Agents; Caffeine; Female; Humans; Male; Marijuana Abuse; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1995 |
Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats.
Topics: Amphetamine; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Ganglia, Sensory; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Schizophrenia; Time Factors; Tubocurarine | 1995 |
Haloperidol increases smoking in patients with schizophrenia.
Topics: Adult; Carbon Monoxide; Female; Haloperidol; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking | 1995 |
Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
Topics: Adult; Attention; Evoked Potentials, Auditory; Female; Hippocampus; Humans; Male; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Temporal Lobe | 1993 |
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Diseases; Central Nervous System Stimulants; Disease Models, Animal; Female; Hippocampus; Ibotenic Acid; Male; Maze Learning; Mecamylamine; Memory; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Random Allocation; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Scopolamine | 1996 |
Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Reference Values; Schizophrenia; Schizophrenic Psychology; Self Administration; Smoking | 1997 |
Smoking cessation and clozapine side effects.
Topics: Antipsychotic Agents; Clozapine; Drug Interactions; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Smoking Cessation | 1998 |
Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: psychiatric implications.
Topics: Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Motor Activity; Nicotine; Schizophrenia | 1998 |
Does clozapine affect smoking rates?
Topics: Clozapine; Drug Interactions; Humans; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention | 1998 |
Smoking and therapeutic response to clozapine in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Reference Values; Schizophrenia; Smoking; Treatment Outcome | 1999 |
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Bungarotoxins; Dopamine Agonists; Female; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Quinolizines; Quinpirole; Rats; Receptors, Nicotinic; Schizophrenia; Yawning | 1999 |
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.
Topics: Aged; Aged, 80 and over; Bungarotoxins; Dementia; Humans; Lewy Bodies; Middle Aged; Neurons; Nicotine; Receptors, Nicotinic; Reference Values; Schizophrenia; Thalamus | 1999 |
Development of nicotinic drug therapy for cognitive disorders.
Topics: Adult; Alzheimer Disease; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Disease Models, Animal; Drug Design; Humans; Learning; Memory; Nicotine; Nicotinic Agonists; Rats; Schizophrenia; Smoking | 2000 |
Smoking and schizophrenia: abnormal nicotinic receptor expression.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Chromosome Mapping; Chromosomes, Human, Pair 15; Cloning, Molecular; Disease Models, Animal; Gene Expression; Humans; Leukocytes, Mononuclear; Mice; Nicotine; Receptors, Nicotinic; Schizophrenia; Smoking | 2000 |
The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia.
Topics: Adult; Attention; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Models, Neurological; Neural Inhibition; Nicotine; Schizophrenia | 2000 |
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neostriatum; Neurodegenerative Diseases; Nicotiana; Nicotine; Parkinson Disease; Plants, Toxic; Radioligand Assay; Receptors, Dopamine D2; Receptors, Nicotinic; Schizophrenia; Sex Factors; Synapses; Tritium | 2000 |
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.
Topics: Aconitine; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Antipsychotic Agents; Brain; Bridged Bicyclo Compounds, Heterocyclic; Child; Female; Haloperidol; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pyridines; Rats; Receptors, Nicotinic; Regression Analysis; Schizophrenia; Smoking | 2000 |
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
Topics: Adult; Biogenic Monoamines; Brain Diseases; Brain Neoplasms; Digoxin; Epilepsy, Generalized; Erythrocytes; Fatty Acids, Nonesterified; Female; Glioma; Glycine Agents; Humans; Hydroxymethylglutaryl CoA Reductases; Kynurenic Acid; Magnesium; Male; Microvascular Angina; Middle Aged; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinolinic Acid; Schizophrenia; Serum Albumin; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine; Ubiquinone | 2000 |
Different outcomes after acute and chronic treatment with nicotine in pre-pulse inhibition in Lister hooded rats.
Topics: Animals; Brain; Mental Processes; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Reflex, Startle; Schizophrenia | 2000 |
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain.
Topics: Aconitine; Animals; Brain Chemistry; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Antagonists; Haloperidol; Insecticides; Male; Nicotine; Nicotinic Agonists; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Nicotinic; Schizophrenia; Smoking; Spiperone; Tritium | 2001 |
Neuronal nicotinic receptors: no smoke without fire!
Topics: Alzheimer Disease; Cognition; Humans; Memory; Neurons; Nicotine; Receptors, Nicotinic; Schizophrenia; Smoking; Synapses | 2001 |
An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response.
Topics: Animals; Antipsychotic Agents; Brain; Caffeine; Cerebrovascular Circulation; Disease Models, Animal; Haloperidol; Male; Niacin; Nicotine; Rats; Rats, Sprague-Dawley; Schizophrenia; Vasodilation | 2001 |
Schizophrenic patients who smoke have a faster finger tapping rate than non-smokers.
Topics: Adult; Analysis of Variance; Fingers; Humans; Male; Middle Aged; Movement; Nicotine; Nicotinic Agonists; Patients; Psychomotor Performance; Schizophrenia; Smoking | 2002 |
Psychotic pica, nicotinism, and complicated myocardial infarction.
Topics: Adult; Humans; Male; Myocardial Infarction; Nicotine; Pica; Schizophrenia | 1977 |
Negative effects of a smoking ban on an inpatient psychiatry service.
Topics: Adult; Aged; Bipolar Disorder; Chronic Disease; Hospitals, Veterans; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Professional-Patient Relations; Psychiatric Department, Hospital; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome; Violence | 1991 |
Correlation of cigarette-induced increase in serum nicotine levels with arginine vasopressin concentrations in the syndrome of self-induced water intoxication and psychosis (SIWIP).
Topics: Adult; Arginine Vasopressin; Bipolar Disorder; Female; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Neurocognitive Disorders; Nicotine; Psychotic Disorders; Schizophrenia; Smoking; Syndrome; Water Intoxication | 1986 |
Nicotine exposure and tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Schizophrenia; Smoking | 1987 |